"10.1371_journal.pone.0046259","plos one","2012-10-02T00:00:00Z","Chiara Falciani; Luisa Lozzi; Simona Pollini; Vincenzo Luca; Veronica Carnicelli; Jlenia Brunetti; Barbara Lelli; Stefano Bindi; Silvia Scali; Antonio Di Giulio; Gian Maria Rossolini; Maria Luisa Mangoni; Luisa Bracci; Alessandro Pini","Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, Siena, Italy; Dipartimento di Scienze Biochimiche A. Fanelli, Università di Roma, La Sapienza, Roma, Italy; Dipartimento di Scienze e Tecnologie Biomediche, Università di LAquila, LAquila, Italy; SetLance srl, Siena, Italy; Azienda Ospedaliera Universitaria Senese, Policlinico Le Scotte, Siena, Italy","Conceived and designed the experiments: CF LL LB GMR AP. Performed the experiments: SP VL VC JB BL SB SS LL. Analyzed the data: AP GMR LB MLM ADG CF. Contributed reagents/materials/analysis tools: SP VL VC JB BL SB SS LL MLM. Wrote the paper: AP CF GMR LB.","The authors have the following interests: The peptide M33 and molecules it derived from are covered by the following three patents: 1. WO2006006195 B1 Antibacterial peptides and analogues thereof (patent issued); 2. WO2010038220 A1 Peptide sequences, their branched form and use thereof for antimicrobial applications (pending); 3. WO2012010266 A1 Antimicrobial peptide, branched forms and uses thereof for the cure of bacterial infections (pending). The patents WO2006006195 B1 and WO2010038220 A1 were filed by University of Siena and then licensed to the company SetLance srl (www.setlance.com). The patent WO2012010266 A1 was directly filed by SetLance srl. Jlenia Brunetti is employed by SetLance srl. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","10","Chiara Falciani","CF",14,TRUE,5,8,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
